- Fee assured
- Verified this account
- Breast specialist
- Breast surgery
- Breast specialist
Mr Will Sarakbi LMSSA (Lond) LRCP (Lond) LRCS (Eng) MS (University of London) FRCS (Eng) is a Consultant Oncoplastic Breast Surgeon at Croydon University Hospital and Shirley Oaks BMI.
His clinical interests lie within the area of newly developed breast cancer surgery techniques, combining cancer treatment with optimum cosmetic outcomes. He believes in individualised treatment plans, tailored to meet the needs of women diagnosed with breast cancer, and ensures that patients are involved in the decisions relating to their treatment.
He qualified from St George’s, University of London in 2001. After completing his basic surgical training in the South East of England, he spent some time in full time research focusing on breast cancer biology, examining the role of molecular markers, such STS and OATP as prognostic indicators in breast cancer. He was awarded a Masters degree in surgery from the University of London. His research work generated over 22 papers in peer reviewed journals and he presented his findings in national and international conferences in the UK, Europe and the USA. He is also a member of the Intensity Modulated Partial Organ Radiotherapy Trial (IMPORT) trial managemnt group, one of the largest currently running radiotherapy trials in the UK funded by Cancer Research UK, investigating new techniques of delivering radiiotherapy in breast cancer.
Following his research, Mr Sarakbi continued his higher surgical training in the London Deanery, spending almost two years at Guys and St Thomas’ Hospital. Mr Sarakbi was elected to the post of President of the National Breast Trainees Association (The Mammary Fold) (2010) and subsequently to the post of President of the Surgical Oncology Trainees Association (SOTA) (2012). He was selected for the prestigious national Aesthetic and Reconstructive Fellowship, which provided him with world class training in both cosmetic and reconstructive breast surgery. He also spent time training in France at the Leon-Berard Centre in Lyon, working with internationally renowned reconstructive surgeons, where he mastered advanced techniques in breast reconstruction and cosmetic breast surgery, including lipomodelling (fat transfer). Mr Sarakbi has also completed over 25 national and international courses to further develop his skills in both reconstructive and aesthetic breast surgery.
Areas of interest
Breast Lump; Breast pain; Breast Cancer ; Breast reconstruction ; Benign breast disease ; nipple discharge; Cosmetic breast surgery
Anaesthetists worked with
- Dr Ian Lambert Fee Assured
Current NHS consultant posts held
Croydon University Hospital
Mr Sarakbi has completed a period of research at the University of London and his thesis was titled: (The potential role of steroid sulfatase (STS) and organic anion transporter B (OATPB) in predicting clinical outcome in breast cancer).
He was also involved in other projects such as examining the potential clinical applications of mammary ductoscopy, and the potential role of proteomic profiling in early detection of breast cancer.
1. C Kirwan, W Al Sarakbi, HY Chan, AM Thompson, GC Wishart. “Tumour bed localisation for targeted breast radiotherapy: Compliance is proportional to trial-related research activity: Tumour bed clip localisation in breast radiotherapy. ” Eur J Surg Oncol 2014 Feb;40(2):158-62. ( on the behalf of the IMRORT trialists )
2. Al Sarakbi W, Reefy S, Jiang W G, Roberts T, Newbold RF, Mokbel K Evidence of a Tumour Suppressor Function for DLEC1 in Human Breast Cancer. Anticancer Research 2010 Jun;30(6):2481.
3. W Al Sarakbi, W Sasi, W G Jiang, T Roberts, R F Newbold and K Mokbel. The mRNA expression of SETD2 in human breast cancer: correlation with clinic-pathological parameters. BMC Cancer 2009 Aug 21;9:290.
4. . Tullie L, Charkaoui L, Al Sarakbi W, Sever A. Breast augmentation with Collagen injections. BMJ Case Reports. Doi:10.1136/bcr.06.2011.4387.
5. Al Sarakbi W, Reed M J, Salhab M, Jiang W G, Mokbel K. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer. Anticancer Research 2006 Nov-Dec;26(6C):4985-90.
6. Al Sarakbi W, YM Chong, SLJ Williams, AK Sharma, K Mokbel. The mRNA expression of IGF-1 and IGF-1R in human breast cancer: correlation with clinico-pathological parameters. Journal of Carcinogenesis. 2006, 5:16.
7. Al Sarakbi W, Salhab M, Mokbel K. Does mammary ductoscopy have a role in clinical practice? Int Semin Surg Oncol. 2006 Jun 30;3(1):16.
8. Al Sarakbi W, Salhab M, Thomas V, Mokbel K. Is preoperative core biopsy accurate in determining the hormone receptor status in women with invasive breast cancer? Int Semin Surg Oncol. 2005 Aug 22;2:15.
9. Al Sarakbi W, Escobar P, Mokbel K. The potential role of mammary ductoscopy in early detection of breast cancer. Int J Fertil Womens med. 2005 November; Vol 50, (5).
10. Al Sarakbi W, Salhab M, Mokbel K. Dairy products and breast cancer risk: a review of the literature. Int J Fertil Womens med 2005 Nov-Dec;50(6):244-9.
11. Al Sarakbi W, Worku D, Escobar PF, Mokbel K. Breast papillomas: Current management with a focus on a new diagnostic and therapeutic modality. Int Semin Surg Oncol. 2006 Jan 17;3:1.
- LMSSA(Lond) Society of Apothecaries (London) 2001
- LRCP(Lond) Royal College of Physicians (Lond) 2001
- LRCS(Eng) Royal College of Surgeons (Eng) 2001
- MS University of London 2001
- FRCS Royal College of Surgeons of England 2011
- National Aesthetic and Reconstructive Fellowship Training interface group 2013
Reference number 6027127
Details of entry to specialist register
- GMC specialist register, 2013
Affiliations / memberships
Association of Breast Surgery
British Association of Surgical Oncology
Medical Defense Union
- BMI Shirley Oaks Hospital, CR9 8AB
- 13:00 - 17:00
- 020 8655 5500
- BMI Shirley Oaks, Poppy LaneShirley Oaks...
- 18:00 - 20:30
- 020 8655 5500
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details
Shirley Oaks Hospital: 0208 6555500
Sharon Newman (secretary): 07741465586